Showing stories 1 - 10 of about 84
DELCATH SYSTEMS, INC. : INVESTOR NOTICE: The Rosen Law Firm ...
The Rosen Law Firm today announced that a class action lawsuit has been filed on behalf of investors who purchased the securities of Delcath Systems, Inc. (Nasdaq: DCTH) during the period from April 21, 2010 through May 2, 2013, seeking to recover ...
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against ...
Delcath operates as a specialty pharmaceutical and medical device company focusing on the field of oncology, primarily the development of CHEMOSAT/Melblez Kit system, which administers concentrated regional chemotherapy to the liver. The Complaint ...
Related articles »
Pomerantz Law Firm Has Filed a Class Action Against Delcath Systems, Inc. and ...
DELCATH SYSTEMS, INC. : DELCATH REPORTS 2013 FIRST QUARTER ... 4-traders (press release)
Related articles »
NEW YORK, May 8, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Delcath Systems, Inc. ("Delcath" or the "Company") (Nasdaq:DCTH) and certain of its officers. The class action ...
Delcath Systems Inc. (NASDAQ:DCTH) down by 11.08%, Dendreon Corporation ...
GSPInsiderDELCATH SYSTEMS, INC. : DELCATH REPORTS 2013 FIRST QUARTER ... 4-traders (press release)
Related articles »
NASDAQ:DCTH Investor Alert: Lawsuit against Delcath Systems, Inc. filed
The Shareholders Foundation announces that an investor in shares of Delcath Systems, Inc. (NASDAQ:DCTH) filed a lawsuit in the U.S.
DELCATH SYSTEMS, INC. : DELCATH ANNOUNCES POSTING OF BRIEFING ...
FDA Tells Delcath No Approval Without New Clinical Trial TheStreet.com
Related articles »
QUEENSBURY, NY - April 30, 2013 - Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the U.S. Food and Drug Administration (FDA) has published on its website the briefing documents for the upcoming May 2, 2013 Oncologic Drugs Advisory ...
Delcath's Chemotherapy Device Has Risks, FDA Staff Says (2)
BusinessweekFDA Tells Delcath No Approval Without New Clinical Trial TheStreet.com
Related articles »
Delcath Systems, Inc. Sued by Investor
SAN DIEGO and NEW YORK, May 10, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP announce that a shareholder of Delcath Systems, Inc. (NASDAQ: DCTH) filed a federal securities fraud class action complaint on May 8, 2013, ...
Related articles »
Delcath Systems, Inc. (NASDAQ:DCTH) Under Investigation, Down 43.86%
FDA Commitee: Benefits of Delcath's Liver-Cancer Treatment Don't ... Wall Street Journal
Related articles »
Northern, WI 05/03/2013 (GDPInsider) - Delcath Systems, Inc. (NASDAQ:DCTH) is taking a hit today after opening at 0.38.
Stocks Up For The Day: Organovo Holdings Inc (OTCMKTS:ONVO), Delcath ...
NISFDA Commitee: Benefits of Delcath's Liver-Cancer Treatment Don't ... Wall Street Journal
Related articles »
Celsion Corporation (NASDAQ:CLSN) Up 11.57%, Delcath Systems, Inc ...
Celsion has been on the watch list for many analysts and the biotech company has been showing promise with two new drugs which it hopes will help fight liver cancer in patients.
Related articles »
DELCATH SYSTEMS, INC. : Delcath Systems Shareholder Alert: Briscoe Law ...
Delcath Systems, Inc. : Delcath Systems Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors.
Related articles »
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Delcath ...
NEW YORK, May 3, 2013 /PRNewswire via COMTEX/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Delcath Systems, Inc. ("Delcath" or the "Company") ...
Related articles »